Market Place
Sourcing Support
Alpha Tau: 100% Local Control, 67% Response in Glioblastoma Trial
11 May 2026 //
GLOBENEWSWIRE
Alpha Tau Fills Pivotal Skin Cancer Trial, Eyes FDA DaRT Approval
08 May 2026 //
GLOBENEWSWIRE
Alpha Tau to Host Call on First GBM Patient Interim Results
08 May 2026 //
GLOBENEWSWIRE
Alpha Tau Treats First Pancreatic Cancer Patient in Italy
07 May 2026 //
GLOBENEWSWIRE
Alpha Tau`s DaRT Shows 100% Local Control in Pancreatic Cancer
04 May 2026 //
GLOBENEWSWIRE
Alpha Tau Showcase 3 Alpha DaRT Pancreatic Cancer Studies at ASCO
27 Apr 2026 //
GLOBENEWSWIRE
Alpha Tau Treats First EU Pancreatic Cancer Patient with DaRT
23 Apr 2026 //
GLOBENEWSWIRE
Alpha Tau Expands Alpha Dart Trial To Pancreatic Cancer
23 Apr 2026 //
GLOBENEWSWIRE
Alpha Tau Presents DaRT Pancreatic Cancer Data at DDW 2026
31 Mar 2026 //
GLOBENEWSWIRE
Alpha Tau To Present At Sidoti March Virtual Small Cap Conference
16 Mar 2026 //
GLOBENEWSWIRE
Alpha Tau Unveils 2025 Financials, Updates Corporate Progress
09 Mar 2026 //
GLOBENEWSWIRE
Japan Approves Alpha DaRT for Head & Neck Cancer
24 Feb 2026 //
GLOBENEWSWIRE
Alpha Tau`s Letter To Shareholders Highlights Five U.S. Trials
29 Jan 2026 //
GLOBENEWSWIRE
Alpha Tau Presents DaRT Study Results at 2026 ASCO GI Symposium
06 Jan 2026 //
GLOBENEWSWIRE
Alpha Tau Submits First Alpha DaRT PMA for cSCC Carcinoma to FDA
05 Jan 2026 //
GLOBENEWSWIRE
Alpha Tau To Present At J.P. Morgan 2026 Healthcare Conference
18 Dec 2025 //
GLOBENEWSWIRE
Alpha Tau Treats First U.S. Recurrent Glioblastoma Patient
09 Dec 2025 //
GLOBENEWSWIRE
Alpha Tau To Present Two Alpha Dart Pancreatic Cancer Abstracts
04 Dec 2025 //
GLOBENEWSWIRE
Alpha Tau Wins FDA Nod for Locally Recurrent Prostate Cancer
02 Dec 2025 //
GLOBENEWSWIRE
Alpha Tau To Participate In December Investor Conferences
01 Dec 2025 //
GLOBENEWSWIRE
Alpha Tau Unveils Q3 2025 Financials And Corporate Update
20 Nov 2025 //
GLOBENEWSWIRE
Alpha Tau To Present At Jefferies Global Healthcare Conference
11 Nov 2025 //
GLOBENEWSWIRE
Alpha Tau Gets Radioactive License For New Manufacturing Site
21 Oct 2025 //
GLOBENEWSWIRE
Alpha Tau Treats First U.S. Patient in Pancreatic Cancer Trial
02 Sep 2025 //
GLOBENEWSWIRE
Alpha Tau to Participate in Five September Investor Conferences
27 Aug 2025 //
GLOBENEWSWIRE
Alpha Tau Q2 2025 Financial Results and Corporate Update
11 Aug 2025 //
GLOBENEWSWIRE
Alpha Tau to Present at Jefferies Global Healthcare Conference
28 May 2025 //
GLOBENEWSWIRE
Alpha Tau`s Q1 2025 Financial Results and Corporate Update
19 May 2025 //
GLOBENEWSWIRE
Alpha Tau appoints Nadav Kidron to Board of Directors
12 May 2025 //
GLOBENEWSWIRE
Alpha Tau to Participate in May Investor Conferences
06 May 2025 //
GLOBENEWSWIRE
Alpha Tau Announces Closing of $36.9M Registered Direct Offering
28 Apr 2025 //
GLOBENEWSWIRE
Oramed Pharma Announces $36.9M Investment and Collaboration
28 Apr 2025 //
PR NEWSWIRE
Alpha Tau gets FDA approval for trial on recurrent glioblastoma
02 Apr 2025 //
GLOBENEWSWIRE
Alpha Tau announces 2024 financial results and corporate update
12 Mar 2025 //
GLOBENEWSWIRE
Alpha Tau to Participate in March Investor Conferences
27 Feb 2025 //
GLOBENEWSWIRE
Alpha Tau gets MDSAP certification
24 Feb 2025 //
GLOBENEWSWIRE
Alpha Tau Announces FDA IDE Approval for Pancreatic Cancer Trial
03 Feb 2025 //
GLOBENEWSWIRE
Alpha Tau To Share Interim Data Across Multiple Trials
27 Jan 2025 //
GLOBENEWSWIRE
Alpha Tau to Present Data at 2025 ASCO GI Symposium
18 Dec 2024 //
GLOBENEWSWIRE
Alpha Tau Appoints Maya Netser to Board, Meir Jakobsohn Steps Down
17 Dec 2024 //
GLOBENEWSWIRE
Alpha Tau to Present at 43rd Annual J.P. Morgan Health Conference
11 Dec 2024 //
GLOBENEWSWIRE
Alpha Tau to Attend Ladenburg’s Oncology Innovators Symposium
06 Dec 2024 //
GLOBENEWSWIRE
Alpha Tau Medical Announces Q3 2024 Financial Results & Update
19 Nov 2024 //
GLOBENEWSWIRE
Alpha Tau to Attend Citi & Piper Sandler Healthcare Conferences
13 Nov 2024 //
GLOBENEWSWIRE
Alpha Tau Accepted Into FDA’s Advisory For Alpha DaRT Access
21 Oct 2024 //
GLOBENEWSWIRE
Alpha Tau Treats First Patient with Recurrent Lung Cancer
10 Oct 2024 //
GLOBENEWSWIRE
FDA Approves Alpha Tau`s Alpha DaRT Study For cSCC
20 Sep 2024 //
GLOBENEWSWIRE
Alpha Tau To Participate In Multiple Investor Conferences
22 Aug 2024 //
GLOBENEWSWIRE
Alpha Tau Medical Announces Q2 2024 Financial Results And Corporate Update
14 Aug 2024 //
GLOBENEWSWIRE
Alpha Tau Publishes Long-Term Safety and Efficacy Data in Cancers Journal
25 Jun 2024 //
GLOBENEWSWIRE
Alpha Tau to Present at the Jefferies Global Healthcare Conference
21 May 2024 //
GLOBENEWSWIRE
Alpha Tau Medical Reports Q1 2024 Financials, Corporate Update
20 May 2024 //
GLOBENEWSWIRE
Alpha Tau Announces First Liver Metastases Patient Treated With Alpha DaRT
13 May 2024 //
GLOBENEWSWIRE
Alpha Tau Shows Pancreatic Cancer Abscopal Effect Preclinically
06 May 2024 //
GLOBENEWSWIRE
Alpha Tau to Participate in May Investor Conferences
01 May 2024 //
GLOBENEWSWIRE
Alpha Tau to Present at the Jefferies Radiopharma Innovation Summit
25 Mar 2024 //
GLOBENEWSWIRE
Alpha Tau to Participate in Barclays 26th Annual Global Healthcare Conference
26 Feb 2024 //
GLOBENEWSWIRE
Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare Conference
20 Dec 2023 //
GLOBENEWSWIRE
Alpha Tau to Participate in Sidoti Small-Cap Conference
29 Nov 2023 //
GLOBENEWSWIRE
Alpha Tau Announces Promising Interim Results from Trial of Alpha DaRT Treatment
28 Nov 2023 //
GLOBENEWSWIRE
